Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by NSX001on May 11, 2021 3:21pm
228 Views
Post# 33175393

Why all of the discussions about Financing

Why all of the discussions about FinancingI don't understand all the fascination and disappointment with something that's a necessity in the pharmaceutical industry. Money is always needed for research and development, so until there is a revenue stream to self finance, it will happen again.

Stop complaining and accept the inevitable. The deed is done and there's no point in discussing it further. Take advantage of the lower price and buy some more , these new investors bought in at $0.40, with warrants at $0.51 in two years. The shares are trading at $0.36 - $0.37, that's below their purchase price, how long do you think they'll stay there?

They didn't invest $10 million dollars at $0.40 just so they can sell them later at $0.40.

NSX001
<< Previous
Bullboard Posts
Next >>